SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in a Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs